Skip to main content
SpringerLink
Log in

Pulmonary Infections in Myelosuppressed or Immunosuppressed Patients

  • Chapter
Developments in Antibiotic Treatment of Respiratory Infections

Part of the book series: New Perspectives in Clinical Microbiology ((NPCM,volume 4))

  • 63 Accesses

Abstract

In patients with defective host defense mechanisms, pulmonary infections are frequent causes of morbidity and mortality. In this review only the treatment of these infections in patients with myelosuppression and patients with immunosuppression will be discussed; disorders of humoral immunity will not be dealt with.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 39.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 54.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Bodey GP, Buckley M, Sathe YS, Freireich EJ: Quantitative relationship between circulating leucocytes and infection in patients with acute leukemia. Ann Int Med 64: 328, 1966.

    PubMed  CAS  Google Scholar 

  2. Van der Meer JWM, Boekhout M, Alleman M: Infectious episodes in severely granulocytopenic patients. Infection 7: 171, 1979.

    Article  PubMed  Google Scholar 

  3. Johanson WG, Pierce AK, Sanford JP: Changing pharyngeal bacterial flora of hospitalized patients. Emergence of Gram-negative bacilli. New Engl J Med 281: 1137, 1969.

    Article  PubMed  CAS  Google Scholar 

  4. Pollack M, Charache P. Nieman RE, Jett MP, Reinhardt JA, Hardy PH: Factors influencing colonisation and antibiotic-resistance patterns in Gram-negative bacteria hospital patients. Lancet 2: 688, 1972.

    Google Scholar 

  5. Van der Waay D, De Vries JM, Lekkerkerk JEC: Colonisation resistance of the digestive tract in conventional and antibiotic treated mice. J Hyg (Lond) 69: 405, 1971.

    Article  Google Scholar 

  6. Aisner J, Murillo J, Schimpff SC, Steere AC: Invasive aspergillosis in acute leukemia correlation with nose culture and antibiotic use. Ann Int Med 90: 4, 1979.

    PubMed  CAS  Google Scholar 

  7. Sickles EA, Young VM, Greene WH, Wiernik PH: Pneumonia in acute leukemia. Ann Int Med 79: 528, 1973.

    PubMed  CAS  Google Scholar 

  8. Schimpff SC, Young VM, Greene WH, Vermeulen GD, Moody MR, Wiernik PH: Origin of infection in acute nonlymphocytic leukemia. Significance of hospital acquisition of potential pathogens. Ann Int Med 77: 707, 1972.

    PubMed  CAS  Google Scholar 

  9. Ries K, Levison Me, Kaye D: Transtracheal aspiration in pulmonary infection, Arch Int Med 133: 453, 1974.

    Article  CAS  Google Scholar 

  10. De Freitas JL, Borst J, Meenhorst PL: Easy visualisation of Legionella pneumophila by ‘half-aGram’ stain procedure. Lancet L•270, 1979.

    Google Scholar 

  11. Myerowits RL, Pasculle AW, Dowling JN, Pazin GJ, Puerzer M, Yee RB, Rinaldo Jr CR, Hakala Tr: Opportunistic lung infection due to `Pittsburgh pneumonia agent’. New Eng J Med 301: 953, 1979.

    Article  Google Scholar 

  12. Kunst MW, Mattie H: Absorption of pivampicillin in postoperative patients. Antimicrob. Ag Chemother 8: 11, 1975.

    CAS  Google Scholar 

  13. Mattie H, Meenhorst PL: Clinical pharmacological evaluation of aminopenicillin. Infection, suppl 5: 456, 1979.

    Article  Google Scholar 

  14. Kunst MW, Mattie H, Van Furth R: Antibacterial efficacy of cefazolin and cephradine in neutropenic mice. Infection 7: 30, 1979.

    Article  PubMed  CAS  Google Scholar 

  15. Bakker-Woudenberg IAJM, Van Gerven ALEM, Michel MF: Efficacy of antimicrobial therapy in experimental rat pneumonia: antibiotic treatment schedules in rats with impaired phagocytosis. Infect Immun 25: 376, 1979.

    PubMed  CAS  Google Scholar 

  16. Bodey GP, Middleman E, Umsawadi T, Rodriquez V: Infections in cancer patients. Results with gentamicin sulfate therapy. Cancer 29: 1697, 1972.

    Article  PubMed  CAS  Google Scholar 

  17. Dale DC, Reynolds HY, Pennington JE, Elin RJ, Herzig GP: Experimental Pseudomonas pneumonia in leukopenic dogs: comparison of therapy with antibiotics and granulocyte transfusions. Blood 47: 869, 1976.

    PubMed  CAS  Google Scholar 

  18. Mattie H, Van der Voet B: The relative potency of amoxicillin and ampicillin in vitro and in vivo. Scand J Infect Dis. Accepted for publication.

    Google Scholar 

  19. Keating MJ, Bodey GP, Valdivieso M: A randomized comparative trial of three aminoglycosides-Comparison of continuous infusions of gentamicin, amikacin and sisomicin combined with carbenicillin in the treatment of infections in neutropenic patients with malignancies. Medicine (Baltimore) 58: 159, 1979.

    CAS  Google Scholar 

  20. Nauta EH, Van Furth R: Infection in immunosuppressed patients. Infection 4: 202, 1975.

    Article  Google Scholar 

  21. Schimpff SC, Moody M, Young VM: Relationship of colonization with Pseudomonas aeruginosa to development of pseudomonas bacteremia in cancer patients. Antimicrob Ag Chemother Jaarboek 240. 1970.

    Google Scholar 

  22. Bodey GP, Rodriquez V: Advances in the management of Pseudomonas aeruginosa infections in cancer patients. Europ J Cancer 9: 435, 1973.

    CAS  Google Scholar 

  23. Meyer DV, Winston D, Young LS, Gale RP, Martin WJ: Surveillance cultures in immunosuppressed patients: what do they mean? In: Current chemotherapy and infectious disease. Proceedings of the 11th international congress of chemotherapy and the 19th interscience conference on antimicrobial agents and chemotherapy ( Nelson JD, Grassi C, eds.), Washington DC, American Soc. for Microbiology, 1980, p. 1436.

    Google Scholar 

  24. Schimpff SC, Satterlee W, Young ME, Serpick A: Empiric therapy with carbenicillin and gentamicin for febrile patients with cancer and granulocytopenia. New Engl J Med 284: 1061, 1971.

    Article  PubMed  CAS  Google Scholar 

  25. Tattersall MHN, Spiers ASD, Darrell JH: Initial therapy with combinations of five antibiotics in febrile patients with leukaemia and neutropenia. Lancet I: 162, 1972.

    Google Scholar 

  26. EORTC international antimicrobial therapy project group. Three antibiotic regimens in the treatment of infection in febrile granulocytopenic patients with cancer. J Infect Dis 137: 14, 1978.

    Article  Google Scholar 

  27. Medoff G, Kobayashi GS: Strategies in the treatment of systemic fungal infections. New Engl J Med 302: 145, 1980.

    Article  PubMed  CAS  Google Scholar 

  28. Higby DJ, Yates JW, Hendurson ES, Holland JF: Filtration leukopheresis for granulocyte transfusion therapy: clinical and laboratory studies. New Engl J Med 292: 761, 1975.

    Article  PubMed  CAS  Google Scholar 

  29. Hertzig RH, Hertzig GP, Graw RG, Bull MI, Rai KK: Successful granulocyte transfusion therapy for Gramnegative septicemia. New Engl J Med 296: 701, 1977.

    Article  Google Scholar 

  30. Alavi JB, Root RK, Djerassi I, Evans AE, Gluckmann SJ, McGregor RR, Dupont G, Schryber AD, Schaw JM, Koch P. Cooper RA: A randomized clinical trial of granulocyte transfusion for infection in acute leukemia. New Engl J Med. 296: 706, 1977.

    Article  PubMed  CAS  Google Scholar 

  31. Rosenshein MS, Farewell VT, Price TH, Larson EB, Dale DC: The cost effectiveness of therapeutic and prophylactic leukocyte transfusion. New Engl J Med 302: 1058, 1980.

    Article  PubMed  CAS  Google Scholar 

  32. Eernisse JG, Van der Meer JWM: Granulocyte transfusions. Neth J Med 22: 128, 1979.

    PubMed  CAS  Google Scholar 

  33. Young LS: Leucocyte transfusions In: Current chemotherapy and infectious disease. Proceedings of the 11th international congress of chemotherapy and the 19th interscience conference on antimicrobial agents and chemotherapy (Nelson JD, Grassi C eds.), Washington DC, American Soc. for Microbiology, 1980, p. 1431.

    Google Scholar 

  34. Guiot HFL: Prevention of infection and partial antibiotic decontamination. Neth J Med 22: 114, 1979.

    Google Scholar 

  35. Van der Waay D: Protective isolation for prevention of infection in patients with severly decreased resistance. Neth J Med 22: 112, 1979.

    Google Scholar 

  36. Editorial. Infection complicating severe granulopenia. Lancet 1: 25, 1980.

    Google Scholar 

  37. EORTC gnotobiotic project group, writing committee: Protective isolation and antimicrobial decontamination in patients with high susceptibility to infection I. Clinical results. Infection 5: 107, 1977.

    Google Scholar 

  38. Levine AS, Siegel SE, Schreiber AD, Hauser J. Preisler HD, Goldstein IM, Seider F, Simon R, Perry S, Bennet JE, Henderson ES: Protected environments and prophylactic antibiotics. A prospective controlled study of their utility in the therapy of acute leukemia. New Engl J Med 288: 477, 1973.

    Article  PubMed  CAS  Google Scholar 

  39. Schimpff SC, Greene WH, Young VM, Fortner CL, Jepsen L, Cusack N, Block JB, Wiernik PH: Infection prevention in acute nonlymphocytic leukemia. Ann Int Med 82: 351, 1975.

    PubMed  CAS  Google Scholar 

  40. Guiot HFL, Van Furth R: Partial antibiotic decontamination. Brit Med J 1: 800, 1977.

    Article  PubMed  CAS  Google Scholar 

  41. Gurwith MJ, Brunton JL, Lash B: A prospective controlled investigation of prophylactic trimethoprim/sulphamethoxazole in hospitalized granulocytopenic patients. Am J Med 66: 248, 1979.

    Article  PubMed  CAS  Google Scholar 

  42. Claas FHJ, Van der Meer JWM, Langerak J: Immunological effect ofcotrimoxazole on platelets. Brit Med J 2: 898, 1979.

    Article  PubMed  CAS  Google Scholar 

  43. Frisch JM: Clinical experience with adverse reactions to trimethoprim sulphamethoxazole. J Infect Dis (Suppl) 128: 607, 1973.

    Google Scholar 

  44. Dijkmans BAC, Versteeg J, Kauffmann RH, Van den Broek PJ, Eernisse JE, Van Zanten JJ, Bakker W, Kalff MW, Van HooffJP: Treatment of cytomegalovirus pneumonitis with hyperimmune plasma, Lancet 1: 820, 1979.

    Article  PubMed  CAS  Google Scholar 

  45. Selby PJ, Powles RL, Jameson B, Kay HEM, Watson JG, Thornton R, M orgenstern G, Clink HM, McElwain TJ, Prentice HG, Corringham R, Ross MG, Hoffbrand AW, Brigden D: Parenteral acyclovir therapy for herbes virus infections in man. Lancet 2: 1267, 1979.

    Article  PubMed  CAS  Google Scholar 

  46. Wolinsky E: Nontuberculous mycobacteria and associated diseases. Am Review Resp Dis 119: 107, 1979.

    CAS  Google Scholar 

  47. Maderazo EG, Quintiliani R: Treatment of nocardial infection with trimethoprim and sulfamethoxazole. AM J Med 57: 671, 1974.

    Article  PubMed  CAS  Google Scholar 

  48. Bach MC, Monaco AP, Finland M: Pulmonary nocardiosis therapy with minocycline and with erythromycin plus ampicillin. JAMA 224: 1378, 1973.

    Article  PubMed  CAS  Google Scholar 

  49. Harrison HR, English MG, Lee CK, Alexander ER: Chlamydia trachomatis infant pneumonitis. Comparison with matched controls and other infant pneumonitis. New Engl J Med 298: 702, 1978.

    Article  PubMed  CAS  Google Scholar 

  50. Tack KJ, Peterson PK, Rasp FL, O’leary M, Hanto D, Simmons RL, Sabbath LD: Isolation of Chamydia trachomatis from the lower respiratory tract of adults. Lancet I: 116, 1980.

    Google Scholar 

  51. Medoff G, Comfort M, Kobayashi GS: Synergistic action of amphotericin B and 5-fluorocytosine against yeastlike organisms. Proc Soc Exp Biol Med 138: 571, 1971.

    PubMed  CAS  Google Scholar 

  52. Block ER, Bennet JE: The combined effect of 5-fluorcytosine and amphotericin B in the therapy of murine cryptococcosis. Proc Soc Exp Biol Med 142: 476, 1976, 1973.

    Google Scholar 

  53. Bennett JE, Dismukes WE, Duma RJ, Medoff G, Sande MA, Gallis H, Leonard J, Fields BT, Bradshaw M, Haywood H, McGee ZA, Cate TR, Cobbs CG, Warner JF, Ailing DW: A comparison of amphotericin B alone and combined with flucytosine in the treatment of cryptococcal meningitis. New Engl J Med 301: 126, 1979.

    Article  PubMed  CAS  Google Scholar 

  54. Hughes WT, Feldman S, Sanyal SK: Treatment of Pneumocystis carinii pneumonitis with trimethoprim-sulfamethoxazole. Canadian Med Ass J 112: 47, 1975.

    CAS  Google Scholar 

  55. Krick JA, Remington JS: Toxoplasmosis in the adult — an overview. New Engl J Med 298: 550, 1978.

    Article  PubMed  CAS  Google Scholar 

Download references

Authors
  1. J. W. M. Van Der Meer
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Department of Infectious Diseases, University Hospital, Leiden, The Netherlands

    Ralph Van Furth

Rights and permissions

Reprints and permissions

Copyright information

© 1981 Martinus Nijhoff Publishers, The Hague

About this chapter

Cite this chapter

Van Der Meer, J.W.M. (1981). Pulmonary Infections in Myelosuppressed or Immunosuppressed Patients. In: Van Furth, R. (eds) Developments in Antibiotic Treatment of Respiratory Infections. New Perspectives in Clinical Microbiology, vol 4. Springer, Dordrecht. https://doi.org/10.1007/978-94-009-8305-2_18

Download citation

  • DOI: https://doi.org/10.1007/978-94-009-8305-2_18

  • Publisher Name: Springer, Dordrecht

  • Print ISBN: 978-94-009-8307-6

  • Online ISBN: 978-94-009-8305-2

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation